CSI Market
Sign In | Register

Np Life Sciences Health Industry Group Inc (NPLS) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access NPLS Annual Income Statement →
Income statement data covering Np Life Sciences Health Industry Group Inc–Dec 31 2022 offers a view into how Dec 31 2023's operating results have moved alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
Q4 2023 		(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax0.01
Total Revenue0.01
Costs & Expenses
Gross Profit0.01
Selling, Administration, Marketing0.05
Other Operating Expense / -Income0.00
Total operating costs including COS0.05
Operating income / -loss-0.04
Interest Expense0.00
Interest Income0.00
Net Interest Expense / -Income0.00
Other loss / -income0.00
Total costs & expenses0.05
Income & Taxes
Income / -loss before income taxes-0.04
Income taxes expenses / -benefit0.00
Income after income taxes-0.04
Net income / -loss of other equity-0.04
Income / -loss from continuing operations-0.04
Discontinued operations0.04
Net income / -loss-0.04
Income / -loss to shareholder-0.04
EBIT-0.04
EBITD-0.04
EBITDA-0.04
Earnings Per Share
Basic EPS (excl. extra items)0.00
Basic Net EPS0.00
Basic shares outstanding (Mill. of Units)42.96
Diluted Net EPS0.00
Diluted average shares (Mill. of Units)42.96
4 historic quarters locked

Sign in to unlock the full Np Life Sciences Health Industry Group Inc income statement history.

Sign In Create Free Account

About NPLS Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: n/a

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.